About this trial
The study is intended to include all patients who will undergo surgical reconstruction of the anterior cruciate ligament (ACL). The patients will be monitored and evaluated preoperatively and also at 6 months and 1, 2 and 5 years after the intervention through a clinical visit or telephone interview. Such assessments will include the administration of questionnaires to determine the patient's functional symptoms and the objective examination of the knee during a medical examination to quantify its stability.
Eligibility criteria
Qualifiers
Patients who have provided informed written written consent;
Patients aged between 18 and 60;
Patients undergoing reconstructive surgical treatment of the anterior cruciate ligament (ACL)
Disqualifiers
Patients unable to understand and to want;
Patients who have not signed informed consent;
Trial design
Treatments tested in this trial
- ACL reconstruction
Treatment groups
Locations
1Sponsors and collaborators
Stefano Zaffagnini
Lead sponsor
Istituto Ortopedico Rizzoli
Sponsor institution